The prognostic significance of changes in lesion size of established cerebral infarcts on computed tomography of the brain

Cerebrovascular Diseases

Volumn 17, Issue 4, 2004, Pages 320-325

  De Reuck, J ^a   Paemeleire, K ^a   Van Maele, G ^a   Goethals, M ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cerebral infarct; Delayed cerebral damage; Lesion size on computed tomography; Stroke outcome

Indexed keywords

ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN MAPPING; CIRCULATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISABILITY; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; SURFACE PROPERTY; SURVIVAL; SYMPTOM; X RAY;

BRAIN; CEREBRAL INFARCTION; DISABILITY EVALUATION; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 2442508706     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077343     Document Type: Article

References (30)

1. De Reuck J, Van De Velde E, Van Maele G, Wissaert W: The prognostic significance of changes in X-ray attenuation on CT in established cerebral infarcts. Cerebrovasc Dis 2003;16:114-121.
2. Von Kummer R, Meyding-Lamade U, Forsting M, Rosin L, Rieke K, Hacke W, Sartor K: Sensitivity and prognostic value of early computed tomography in middle cerebral artery trunk occlusion. Am J Neuroradiol 1994;15:9-15.
3. Hacke W, Kaste M, Fieschi C et al, for the ECASS Study Group: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). J Am Med Assoc 1995;274:1017-1025.
4. Moulin T, Cattin F, Crepin-Leblond T, Tatu L, Chavot D, Piotin M, Viel JF, Rumbach L, Bonneville JF: Early CT signs in acute middle cerebral artery infarction: Predictive value for subsequent infarct location and outcome. Neurology 1996;47:366-375.
5. International Stroke Trial Collaborative Group: The International Stroke Trial (IST): A randomized trial on aspirin, subcutaneous heparin, both or neither among 19,435 patients with acute ischaemic stroke. Lancet 1997;349:1569-1581.
6. Toni D, Fiorelli M, Bastianello S, Falcou A, Sette G, Ceschin V, Sacchetti ML, Argentino C: Acute ischemic strokes improving during the first 48 hours of onset: predictability, outcome and possible mechanisms. Stroke 1997;28:10-14.
7. Wester P, Radberg J, Lundgren B, Peltonen M, for the Seek-Medical- Attention-in-Time Study Group: Factors associated with delayed admission to hospital and in-hospital delays in acute stroke and TIA: A prospective, multicenter study. Stroke 1999;30:40-48.
8. Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, Rorick M, Moomaw CJ, Walker M: Measurements of acute cerebral infarction: A clinical examination scale. Stroke 1989;20:864-870.
9. Heinsius T, Bogousslavsky J, Von Melle G: Large infarcts in the middle cerebral artery territory: Etiology and outcome patterns. Neurology 1998;50:341-350.
10. Wardlaw JM, Lewis SC, Dennis MS, Counsell C, Mc Dowall M: Is visible infarction on computed tomography associated with adverse prognosis in acute ischemic stroke? Stroke 1998;29:1315-1319.
11. Brott T, Marler JR, Olinger CP, Adams H, Tomsick T, Barsan WG, Biller J, Eberle R, Hertzberg V, Walker M: Measurements of acute cerebral infarction. Lesion size by computed tomography. Stroke 1998;20:871-875.
12. Saver JL, Johnston KC, Homer D, Witijk R, Koroshetz W, Truskowski LL, Haley EC, for the RANTTAS investigators: Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. Stroke 1999;30:293-298.
13. Johnston KC, Connors AF Jr, Wagner DP, Knaus WA, Wong XQ, Haley EC Jr, for the Randomized Trial of Tirilazad Mesylate in Acute Stroke (RANTTAS) investigators: A predictive risk model for outcomes of ischemic stroke. Stroke 2000;31:448-455.
14. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-1526.
15. Orgogozo JM, Asplund K, Boysen GA: A unified form for neurological scoring of hemispheric stroke. Stroke 1992;23:1678-1679.
16. Van Swieten JC, Visser MC, Schouten HJA, Van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607.
17. Skriver EB, Olsen TS, Mc Nair P: Mass effect and atrophy after stroke. Acta Radiol 1990;31:431-438.
18. Schwamm LH, Koroshetz WJ, Sorensen AG, Wang B, Copen WA, Budzik R, Rordorf G, Buonanno FS, Schaefer PW, Gonzales RG: Time course of lesion development in patients with acute stroke: Serial diffusion and hemodynamic-weighted magnetic resonance imaging. Stroke 1998;29:2268-2276.
19. Wardlaw JM, Dennis MS, Lindley RI, Warlow CP, Sandecock P, Sellar RJ: Does early reperfusion of a cerebral infarct influence cerebral infarct swelling in the acute stage or the final clinical outcome? Cerebrovasc Dis 1993;3:86-96.
20. Lövblad KO, Baird AE, Schlaug G, Benfield A, Siewert B, Voetsch B, Connor A, Burzynski C, Edelman RR, Warach S: Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol 1997;42:164-170.
21. Van Everdingen KJ, van der Grond J, Kapelle LJ, Ramos LM, Mali WP: Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke 1998;29:1782-1790.
22. Thijs VN, Lansberg MG, Beaulieu C, Marks MP, Moseley ME, Albers GW: Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariable analysis. Stroke 2000;31:2597-2602.
23. Engelter ST, Provenzale JM, Petrella JR, De Long DM, Alberts MJ: Infarct volume on apparent diffusion coefficient maps correlates with length of stay and outcome after middle cerebral artery stroke. Cerebrovasc Dis 2003;15:188-191.
24. Beaulieu Ch, de Crespiony A, Tong DC, Moseley ME, Albers GW, Marks MP: Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: Evolution of lesion volume and correlation with clinical outcome. Ann Neurol 1999;46:568-578.
25. Dirnagl U, Jadecola C, Moskowitz MA: Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci 1999;22:391-397.
26. Tikka TM, Koistinaho JE: Minocycline provides neuroprotection against N-methyl-D-asparate neurotoxicity by inhibiting microglia. J Immunol 2001;166:7527-7533.
27. Guilian D, Vaca K: Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system. Stroke 1993;24(suppl 12):184-190.
28. Matsui T, Mori T, Tateishi N, Kagamushi Y, Satoh S, Katsube N, Niorikawa E, Morimoto T, Ikuta F, Asano T: Astrocytic activation and delayed infarct expansion after local ischemia in rats. 1. Enhanced astrocytic synthesis of S-100β in the periinfarct area precedes delayed infarct expansion. J Cereb Blood Flow Metab 2002;22:711-722.
29. 55Cobalt as a PET-tracer in stroke, compared with blood flow, oxygen metabolism, blood volume and gadolinium-MRI. J Neurol Sci 1999;171:11-18.
30. De Reuck J, Stevens H, Jansen H, Keppens J, Strijckmans K, Goethals P, Lemahieu I, Santens P, Korf J: The significance of cobalt-55 positron emission tomography in ischemic stroke. J Stroke Cerebrovasc Dis 1999;8:17-21.